CDK7 and small cell lung carcinoma: For instance, CDK7 inhibition by a small inhibitor YKL-5-124 induces DNA replication stress, genome instability and a robust immune surveillance program elicited by T cells, thus a combination of YKL-5-124 and anti-PD-1 shows evident survival benefit in small cell lung cancer [33].